Vistagen Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2012 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2012 to 2023.
  • Vistagen Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 30.6M shares, a 205% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 19.4M shares, a 178% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 6.96M shares, a 5.45% increase from 2021.
  • Vistagen Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 6.6M shares, a 92.3% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 19.4M +12.4M +178% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-11
2022 6.96M +359K +5.45% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 6.6M -79.5M -92.3% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 86.1M Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2015 1.77M +449K +34.1% Apr 1, 2015 Mar 31, 2016 10-K 2016-06-24
2014 1.32M +220K +20% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-24
2013 1.1M -19.7M -94.7% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 20.8M Apr 1, 2012 Mar 31, 2013 10-Q 2014-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.